Impact of Fluid Status on Liver Elastography and T1-mapping Results in Patients Undergoing CMR.

NCT05239260 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2022-02-14

No results posted yet for this study

Summary

Correlation between CMR T1-times, liver T1-times, fibroscan and fluid status to identify the correlation and pathogenesis of liver disease in patients with heart disease.

Conditions

  • NAFLD/MAFLD
  • Liver Fibrosis
  • CMR

Interventions

DIAGNOSTIC_TEST

CMR

CMR

Sponsors & Collaborators

  • Medical University of Vienna

    lead OTHER

Principal Investigators

  • Andreas Kammerlander · Medical University of Vienna

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-02-01
Primary Completion
2022-05-01
Completion
2023-01-01

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05239260 on ClinicalTrials.gov